Enovis (ENOV) Income from Non-Controlling Interests (2012 - 2026)

Enovis' (ENOV) quarterly Income from Non-Controlling Interests came in at $314000.0 in Q2 2026, up 20.31% year-on-year from $261000.0 in Q2 2025, and up 132.59% on a QoQ basis from $135000.0 in Q4 2025.

Enovis (ENOV) Income from Non-Controlling Interests (2012 - 2026) Analysis & Trends

Enovis (ENOV) has 15 years of Income from Non-Controlling Interests data on file, last reported at $314000.0 in Q2 2026.

  • On a quarterly basis, Income from Non-Controlling Interests rose 20.31% year-over-year to $314000.0 in Q2 2026; TTM through Apr 2026 was $873000.0, a 11.49% increase from a year earlier, with the FY2025 full-year figure at $820000.0, up 20.77% from the prior year.
  • Income from Non-Controlling Interests for Q2 2026 stood at $314000.0, up from $135000.0 in the prior quarter.
  • Over the last five years, Income from Non-Controlling Interests for ENOV reached as high as $314000.0 in Q2 2026 and fell as low as $34000.0 in Q4 2022.
  • Historically, Income from Non-Controlling Interests has averaged $176266.7 across 5 years, with a median of $182000.0 in 2023.
  • Across the five-year window, Income from Non-Controlling Interests sank 84.26% in 2022 and soared 547.5% in 2024, its largest moves.
  • Year by year, Income from Non-Controlling Interests stood at $34000.0 in 2022, then surged by 241.18% to $116000.0 in 2023, then advanced by 18.1% to $137000.0 in 2024, then dropped by 1.46% to $135000.0 in 2025, then jumped by 132.59% to $314000.0 in 2026.
  • Per Business Quant data, the three most recent Income from Non-Controlling Interests figures were $314000.0 in Q2 2026, $135000.0 in Q4 2025, and $233000.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 16.00 Mn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -2.00 Mn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 22.00 Mn
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn -5.85 Mn
10 Enovis 1.61 Bn 1.58 Bn 365.49 Mn 314,000.00

Historic Data

Download Data
DateValue
Apr 3, 2026 314,000.00
Dec 31, 2025 135,000.00
Oct 3, 2025 233,000.00
Jul 4, 2025 191,000.00
Apr 4, 2025 261,000.00
Dec 31, 2024 137,000.00
Sep 27, 2024 259,000.00
Jun 28, 2024 126,000.00
Mar 29, 2024 157,000.00
Dec 31, 2023 116,000.00
Sep 29, 2023 40,000.00
Jun 30, 2023 182,000.00
Mar 31, 2023 192,000.00
Dec 31, 2022 34,000.00
Apr 1, 2022 267,000.00
Dec 31, 2021 216,000.00
Oct 1, 2021 191,000.00
Jul 2, 2021 705,000.00
Apr 2, 2021 876,000.00
Dec 31, 2020 -1.55 Mn